Research Paper Volume 13, Issue 11 pp 15548—15568
Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for childhood acute lymphoblastic leukemia
Figure 3. Evaluated the predictive accuracy and discriminative ability of the nomogram (A) Calibration curves of the nomogram for the estimation of survival rates at 3, 5, and 7 years. (B–D) ROC curves at 3, 5, and 7 years according to the nomogram and lncRNA signature score. (E) Kaplan-Meier curves of OS according to the total risk score.